Albuterol Sulfate Inhalation Solution
NDC Package 81075-229-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Albuterol Sulfate Inhalation Solution is a . Marketed by Lexenpharm (suzhou) Limited, this product is identified by NDC 81075-229 and is authorized under FDA application ANDA215571.

Identification & Billing

NDC Package Code
81075-229-01
Package Description
30 POUCH in 1 CARTON / 5 VIAL in 1 POUCH (81075-229-05) / 3 mL in 1 VIAL
Product Code
81075-229
11-Digit Billing Format
81075022901

Clinical Specifications

Proprietary Name
Albuterol Sulfate Inhalation Solution
Dosage Form
-

Regulatory & Marketing

Labeler Name
Lexenpharm (suzhou) Limited
FDA Application #
ANDA215571
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-03-2024
End Marketing Date
09-30-2024
Listing Expiration
09-30-2024
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 81075-229-01 identifies a specific commercial package of 30 pouch in 1 carton / 5 vial in 1 pouch (81075-229-05) / 3 ml in 1 vial of Albuterol Sulfate Inhalation Solution, labeled by Lexenpharm (suzhou) Limited. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Lexenpharm (suzhou) Limited on May 03, 2024. The current certification is valid through September 30, 2024.

How is this Lexenpharm (suzhou) Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 81075022901. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
81075-229-01
11-Digit CMS (5-4-2)
81075-0229-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.